MX2008002299A - Composiciones farmaceuticas que comprenden metales para modular la adhesion celula a celula epitelial. - Google Patents

Composiciones farmaceuticas que comprenden metales para modular la adhesion celula a celula epitelial.

Info

Publication number
MX2008002299A
MX2008002299A MX2008002299A MX2008002299A MX2008002299A MX 2008002299 A MX2008002299 A MX 2008002299A MX 2008002299 A MX2008002299 A MX 2008002299A MX 2008002299 A MX2008002299 A MX 2008002299A MX 2008002299 A MX2008002299 A MX 2008002299A
Authority
MX
Mexico
Prior art keywords
cell
metals
pharmaceutical compositions
cell adhesion
modulating epithelial
Prior art date
Application number
MX2008002299A
Other languages
English (en)
Inventor
Simon J Ward
Alice Macgowan
Michael J Cork
Jonathan Hadgraft
Majella Lane
Adrian Davis
Richard Guy
Original Assignee
York Pharma Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by York Pharma Plc filed Critical York Pharma Plc
Publication of MX2008002299A publication Critical patent/MX2008002299A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/315—Zinc compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Otolaryngology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Se describe una composicion que comprende un compuesto de metal del grupo (2, 4, 12, 13 o 14), farmaceuticamente aceptable, para el tratamiento de una condicion dermatologica que involucra una disminucion anormal en la adhesion celula a celula entre las celulas epiteliales en la barrera epidermica.
MX2008002299A 2005-08-19 2006-08-21 Composiciones farmaceuticas que comprenden metales para modular la adhesion celula a celula epitelial. MX2008002299A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0517043.6A GB0517043D0 (en) 2005-08-19 2005-08-19 Improvements in pharmaceutical compositions
PCT/GB2006/050250 WO2007020479A2 (en) 2005-08-19 2006-08-21 Pharmaceutical compositions comprising metals for modulating epithelial cell-to-cell adhesion

Publications (1)

Publication Number Publication Date
MX2008002299A true MX2008002299A (es) 2008-03-14

Family

ID=35097974

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2008002299A MX2008002299A (es) 2005-08-19 2006-08-21 Composiciones farmaceuticas que comprenden metales para modular la adhesion celula a celula epitelial.

Country Status (12)

Country Link
US (2) US20090123549A1 (es)
EP (2) EP1933828A2 (es)
JP (1) JP2009504723A (es)
KR (1) KR20080036095A (es)
CN (1) CN101291667A (es)
AU (1) AU2006281204A1 (es)
BR (1) BRPI0615179A2 (es)
CA (1) CA2619704A1 (es)
GB (1) GB0517043D0 (es)
MX (1) MX2008002299A (es)
RU (1) RU2008110482A (es)
WO (1) WO2007020479A2 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0617191D0 (en) * 2006-08-31 2006-10-11 York Pharma Plc Improvements in pharmaceutical compositions
GB0715141D0 (en) * 2007-08-03 2007-09-12 York Pharma Plc Improving skin barrier function

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB190512211A (en) * 1905-06-13 1906-02-01 Vincent Thompson A Specific or Salve for the Relief and Cure of Eczema, and the like Skin and Eruptive Diseases, and generally for Complaints caused by Germs or Parasites in the Skin.
US1809082A (en) * 1927-05-04 1931-06-09 Epstein & Harris Product for treating the skin
GB829426A (en) * 1955-09-01 1960-03-02 Allied Lab Inc Corrective shampoos containing cadmium sulfide
AU4216089A (en) * 1988-08-12 1990-03-05 Joel E. Bernstein Method and composition for treating and preventing dry skin disorders
AU629671B2 (en) * 1989-08-03 1992-10-08 Hisamitsu Pharmaceutical Co. Inc. Skin cream preparation for external use
DE69227109T2 (de) 1991-02-05 1999-02-18 Sun Smart, Inc., Wainscott, N.Y. Durchsichtiges, uv absorbierendes sonnenschutzmittel und verfahren zu dessen herstellung
FR2677543B1 (fr) * 1991-06-13 1993-09-24 Oreal Composition cosmetique filtrante a base d'acide benzene 1,4-di(3-methylidene-10-camphosulfonique) et de nanopigments d'oxydes metalliques.
FR2680684B1 (fr) * 1991-08-29 1993-11-12 Oreal Composition cosmetique filtrante comprenant un nanopigment d'oxyde metallique et un polymere filtre.
DE4232143A1 (de) * 1992-09-25 1994-03-31 Claus E Dr Med Lange Topische Pflegemittel oder Arzneimittel, enthaltend feinteiliges transparentes Zinkoxid
US5898037A (en) * 1992-11-13 1999-04-27 Marx; Alvin J. Formulations of magnesium compounds for local application and methods of treatment using the same
DE4238869C2 (de) * 1992-11-18 1994-09-08 Wogepharm Gmbh Mittel zur Behandlung des atopischen Ekzems und anderer entzündlicher Hautkrankheiten
RU2071776C1 (ru) * 1993-08-11 1997-01-20 Белла Яковлевна Качугина Способ лечения респираторных заболеваний
FR2732602B1 (fr) * 1995-04-10 1997-05-09 Oreal Utilisation d'un sel d'un metal alcalino-terreux dans une composition cosmetique ou pharmaceutique pour traiter les prurits
EP0737471A3 (fr) * 1995-04-10 2000-12-06 L'oreal Utilisation d'un sel d'une métal alcalino-terreux comme inhibiteur de TNF-alpha dans une composition unique et composition obtenue
FR2740341B1 (fr) * 1995-10-26 1997-12-19 Oreal Utilisation de sel de lanthanide, d'etain, de zinc, de manganese, d'yttrium, de cobalt, de baryum, de strontium dans une composition pour la peau
JPH1160494A (ja) * 1997-08-21 1999-03-02 Taisho Pharmaceut Co Ltd アトピー性皮膚炎再発防止剤
US6479058B1 (en) * 1999-09-02 2002-11-12 Mccadden Michael E. Composition for the topical treatment of poison ivy and other forms of contact dermatitis
US20030203035A1 (en) * 2000-09-29 2003-10-30 The Procter & Gamble Company Allergen neutralization compositions
US20020150540A1 (en) * 2001-02-08 2002-10-17 Akikazu Yoshikawa Allergen neutralization compositions containing aluminum ions
EP1480517A4 (en) * 2002-02-07 2007-08-22 Univ Columbia ZINC SALT COMPOSITIONS FOR PREVENTING MOLECULAR BREAST EXTRACTION THROUGH SPERMICIDES AND MICROBICIDES
US7695726B2 (en) * 2004-01-23 2010-04-13 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Pigmented cosmetic composition exhibiting radiance with soft focus

Also Published As

Publication number Publication date
EP1938817A2 (en) 2008-07-02
AU2006281204A1 (en) 2007-02-22
GB0517043D0 (en) 2005-09-28
EP1933828A2 (en) 2008-06-25
WO2007020479A2 (en) 2007-02-22
KR20080036095A (ko) 2008-04-24
US20130028986A1 (en) 2013-01-31
WO2007020479A3 (en) 2007-05-24
BRPI0615179A2 (pt) 2011-05-03
US20090123549A1 (en) 2009-05-14
CN101291667A (zh) 2008-10-22
RU2008110482A (ru) 2009-09-27
JP2009504723A (ja) 2009-02-05
CA2619704A1 (en) 2007-02-22
EP1938817A3 (en) 2008-12-03

Similar Documents

Publication Publication Date Title
WO2006138735A3 (en) Gel compositions for topical administration
WO2001083554A3 (en) Anti-inflammatory compounds and uses thereof
UA100228C2 (uk) Фармацевтична композиція, яка містить тетрагідрофолієву кислоту
TW200744588A (en) Pharmaceutical composition for external use
ES2356883A1 (es) Composicion para el tratamiento del dolor y/o la inflamacion.
MY140514A (en) Triazolopyridine derivatives as inhibitors of lipases and phospholipases
WO2007019439A3 (en) Block copolymer compositions and uses thereof
WO2003059898A3 (en) Eponemycin and epoxomicin analogs and uses thereof
GEP20094666B (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
WO2007106537A3 (en) Aminoquinolones as gsk-3 inhibitors
UA94065C2 (en) Dihydropseudoerythromycin derivatives
TW200833370A (en) Pharmaceutical composition containing low substituted hydroxypropylcellulose
MX2012007375A (es) 3-ceto-n-propargil 1-aminoindano.
MY140739A (en) 2, 6-quinolinyl derivatives, processes for preparing them and their uses
JO2578B1 (en) Compounds Theophene benzimidazole
UA96759C2 (en) 2-ARYLINDOLE DERIVATIVES AS mPGES-I INHIBITORS
WO2007133944A3 (en) Topical administration of acyclovir
MX2009003169A (es) Derivados de sulfonamida.
WO2006111960A3 (en) Methods, compositions and devices utilizing stinging cells/capsules for conditioning a tissue prior to delivery of an active agent
GB2456096A (en) Crystalline form of benzothiophene compound and process for preparation thereof
MX2008002299A (es) Composiciones farmaceuticas que comprenden metales para modular la adhesion celula a celula epitelial.
WO2007024752A3 (en) Methods and compositions for the treatment and diagnosis of endothelial cell disorders and angiogenic disorders
WO2008070354A3 (en) 5- and 6- substituted benzimidazole thiophene compounds
GEP20074075B (en) Indazolamides with analgesic activity
UA89408C2 (ru) Твердая фармацевтическая композиция пролонгированного высвобождения 1-(2,3,4-триметоксибензил)пиперазина и способ ее получения

Legal Events

Date Code Title Description
FA Abandonment or withdrawal